INTRODUCTION: A malignant sigmoid colon–duodenal fistula is extremely rare, and optimal management strategies remain unclear.CASE PRESENTATION: A 66-year-old man was admitted to a local hospital with melena. Lower gastrointestinal endoscopy identified a circumferential type 3 tumor located in the sigmoid colon. Upper gastrointestinal endoscopy revealed extrinsic tumor invasion into the horizontal portion of the duodenum. Contrast-enhanced abdominal CT demonstrated irregular thickening of the sigmoid colon wall, which appeared to be contiguous with the horizontal portion of the duodenum, with evidence of luminal continuity. Based on a diagnosis of malignant sigmoid–duodenal fistula, the patient underwent open surgery. At laparotomy, the sigmoid colon cancer was found to be directly invading the duodenojejunal flexure, arising from the ligament of Treitz on the left side of the superior mesenteric artery, which made preservation of the duodenum difficult. Therefore, Hartmann’s procedure with concomitant segmental duodenectomy was performed while preserving the pancreas. For duodenal reconstruction, a Roux-en-Y jejunal limb was created and anastomosed to the second portion of the duodenum. Additionally, a gastrojejunostomy in the Billroth II configuration was performed.CONCLUSIONS: Malignant invasion of the duodenum is often associated with involvement of major vessels or the need for pancreatic resection, which may render curative resection difficult or excessively invasive. However, segmental duodenectomy with preservation of the pancreas can be a valuable surgical option in selected cases.
24 August 2026 in Journal of Hepato-Biliary-Pancreatic Sciences
Background/Objectives: Differentiating pancreatic head cancer (PHC) from distal cholangiocarcinoma (dCCA) remains clinically challenging and directly influences treatment strategy. This study evaluates the clinicopathologic features and outcomes of patients with PHC who were preoperatively designated as dCCA. Methods: We retrospectively analyzed patients undergoing pancreatoduodenectomy for suspected dCCA or PHC from 2019 to 2023. Patients were stratified by pre- and postoperative diagnoses into three groups: confirmed dCCA (B-B), confirmed PHC (P-P), and dCCA reclassified as PHC (B-P). Clinicopathologic features, perioperative outcomes, and survival were compared. Results: This analysis included 159 patients, B-B = 31, P-P = 115, and B-P = 13. Despite a more advanced stage, a lower R0 rate (p = 0.043), and unplanned portal vein resection confined to B-P (p < 0.001), overall and recurrence-free survival were comparable to P-P (p = 0.363 and 0.183). In multivariable Cox analysis, B-P remained an independent favorable prognostic factor for overall survival (Hazard ratio 0.137, p = 0.020). Conclusions: Approximately one-third of cases initially diagnosed as dCCA were ultimately PHC. These PHC cases mimicking dCCA demonstrated comparable or even superior survival, suggesting a biologically indolent subset. Refinement of diagnostic criteria and integrated clinicopathologic assessment are essential for optimizing preoperative management strategies.